Hypertriglyceridemia and acute pancreatitis

AL Yang, J McNabb-Baltar - Pancreatology, 2020 - Elsevier
Hypertriglyceridemia is the third most common cause of acute pancreatitis. It typically occurs
in patients with an underlying disorder of lipoprotein metabolism and in the presence of a …

A modern approach to dyslipidemia

AJ Berberich, RA Hegele - Endocrine Reviews, 2022 - academic.oup.com
Lipid disorders involving derangements in serum cholesterol, triglycerides, or both are
commonly encountered in clinical practice and often have implications for cardiovascular …

[HTML][HTML] Assessment of the course of acute pancreatitis in the light of aetiology: a systematic review and meta-analysis

ER Bálint, G Fűr, L Kiss, DI Németh, A Soós, P Hegyi… - Scientific Reports, 2020 - nature.com
The main causes of acute pancreatitis (AP) are biliary disease, alcohol consumption,
hypertriglyceridaemia (HTG) and endoscopic retrograde cholangiopancreatography …

[HTML][HTML] Pancreatitis: TIGAR-O version 2 risk/etiology checklist with topic reviews, updates, and use primers

DC Whitcomb - Clinical and Translational Gastroenterology, 2019 - ncbi.nlm.nih.gov
Abstract The Toxic-metabolic, Idiopathic, Genetic, Autoimmune, Recurrent and severe acute
pancreatitis and Obstructive (TIGAR-O) Pancreatitis Risk/Etiology Checklist (TIGAR-O_V1) is …

[HTML][HTML] The effect of serum triglyceride concentration on the outcome of acute pancreatitis: systematic review and meta-analysis

L Kiss, G Fűr, P Mátrai, P Hegyi, E Ivány, IM Cazacu… - Scientific reports, 2018 - nature.com
Elevated serum triglyceride concentration (seTG,> 1.7 mM or> 150 mg/dL) or in other words
hypertriglyceridemia (HTG) is common in the populations of developed countries. This …

[HTML][HTML] Development and validation of three machine-learning models for predicting multiple organ failure in moderately severe and severe acute pancreatitis

Q Qiu, Y Nian, Y Guo, L Tang, N Lu, L Wen… - BMC …, 2019 - Springer
Background Multiple organ failure (MOF) is a serious complication of moderately severe
(MASP) and severe acute pancreatitis (SAP). This study aimed to develop and assess three …

[HTML][HTML] Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis

W He, P Chen, Y Lei, L Xia, P Liu, Y Zhu… - Critical …, 2022 - ccforum.biomedcentral.com
Intra-abdominal hypertension (IAH) in acute pancreatitis (AP) is associated with
deterioration in organ function. This trial aimed to assess the efficacy of neostigmine for IAH …

EarLy Elimination of Fatty Acids iN hypertriglyceridemia-induced acuTe pancreatitis (ELEFANT trial): Protocol of an open-label, multicenter, adaptive randomized …

N Zádori, N Gede, J Antal, A Szentesi, H Alizadeh… - Pancreatology, 2020 - Elsevier
Introduction Acute pancreatitis (AP) is a life-threatening inflammatory disease, with no
specific pharmacological treatment. However, concerning some etiologies, early specific …

Severe hypertriglyceridemia-related pancreatitis: characteristics and predictors of recurrence

B Zafrir, W Saliba, A Jubran, R Hijazi, C Shapira - Pancreas, 2019 - journals.lww.com
Objectives The diagnosis of severe hypertriglyceridemia (HTG) as a cause for acute
pancreatitis is often delayed with limited data on the characteristics and predictors of …

Hypertriglyceridemia-related pancreatitis in patients with type 2 diabetes: links and risks

E Shemesh, B Zafrir - … Syndrome and Obesity: Targets and Therapy, 2019 - Taylor & Francis
Disturbances in glucose and lipid homeostasis are cardinal features of the metabolic
syndrome that affect millions of people worldwide. These conditions have multi-organ …